Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Active vitamin D for secondary hyperparathyroidism after bariatric surgery
2022-000178-24Phase 3Active
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of calcitriol in secondary hyperparathyroidism (SHPT) (2 arms). Primary endpoint: Normalization of parathyroid hormone. Started Apr 2023; status: active.
02
Drugs
calcitriol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on 2022-000178-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000178-24.